AURN News — Scientists at City of Hope, a cancer research and treatment institution in California, have made a breakthrough in identifying a crucial cell metabolism process shared by men grappling with diabetes and metastatic prostate cancer.
According to a press release, the discovery holds potential for enhanced diagnostic methods and treatments tailored to Black men, who face disproportionately high mortality rates from these conditions.
Prostate cancer is the second most prevalent cancer in men, and troublingly, Black men exhibit a 70% higher likelihood of diagnosis compared to white men, with a mortality rate two to four times greater than other racial groups, as per the American Cancer Society’s latest data.
City of Hope’s clinical trial, focusing on men of West African heritage, pinpointed four metabolism-related biomarkers connected to an elevated risk of metastatic prostate cancer, providing an essential stride toward more inclusive and effective medical solutions.
Click play to listen to the AURN News report from Jamie Jackson:
